Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,650.00
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 83.00 (5.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets up on positive company news

Wed, 22nd Oct 2014 17:04

The London market closed in positive territory for the second time this week as traders weary of negative economic news took heart from upbeat corporate results.The FTSE 100 Index ended the session 27.4 points ahead at 6399.73 as drug group GlaxoSmithKline pleased investors with news of higher earnings per share despite US and European weakness. It also said it was launching a restructuring drive to cut costs and streamline its business. Glaxo's shares bounced 35p to 1,377p.On the economic front, minutes from the Bank of England's most recent meeting showed no further urge by members to start thinking about raising interest rates, with the split between 'doves' and 'hawks' remaining unchanged from the last meeting at 7-2.Capital Spreads dealer William Nicholls said: "Given the volatility in financial markets of late, there is unlikely to be any move on this sentiment since the meeting, if anything they are likely to become more accommodative."Investors took cover in car insurers after the Automobile Association (AA) said price declines in the industry were over.Admiral Group ticked up 42p to 1285p and Direct Line advanced 8.5p to 279.6p. But the AA itself reversed 2.25p or 0.72% to 310.25p.Supermarkets were on the slide after Waitrose said the business model of the Big Four retailers was outdated and insolvency group Begbies Traynor forecast a bad Christmas unless they make changes.Sainsbury was 8.4p off at 241.6p, Morrisons backtracked 4.2p to 157.9p and Tesco, which releases first-half results tomorrow, fell 2.9p to 183p.British American Tobacco wafted 91.5p lower to 3375p after warning of a foreign exchange hit and weak European markets.Fashion house Supergroup faded 54p to 975p as worries about the impact on sales of warm autumn weather eclipsed news that former Co-op boss Euan Sutherland was to become its new chief executive.Market MoverstechMARK 2,674.09 +1.20%FTSE 100 6,399.73 +0.43%FTSE 250 15,170.06 +0.97%FTSE 100 - RisersAdmiral Group (ADM) 1,285.00p +3.38%Direct Line Insurance Group (DLG) 279.60p +3.14%GlaxoSmithKline (GSK) 1,377.00p +2.61%ARM Holdings (ARM) 827.00p +2.61%Whitbread (WTB) 4,298.00p +2.33%Old Mutual (OML) 181.90p +2.19%Babcock International Group (BAB) 1,079.00p +2.18%Smith & Nephew (SN.) 982.50p +2.13%Dixons Carphone (DC.) 374.30p +2.10%Royal Mail (RMG) 448.70p +1.98%FTSE 100 - FallersSainsbury (J) (SBRY) 241.60p -3.36%Fresnillo (FRES) 784.00p -3.03%British American Tobacco (BATS) 3,375.00p -2.64%Morrison (Wm) Supermarkets (MRW) 157.90p -2.59%Randgold Resources Ltd. (RRS) 4,170.00p -2.55%Rio Tinto (RIO) 3,089.50p -1.61%Tesco (TSCO) 183.00p -1.56%BHP Billiton (BLT) 1,664.50p -1.48%Weir Group (WEIR) 2,258.00p -1.44%Anglo American (AAL) 1,356.50p -1.31%FTSE 250 - RisersPace (PIC) 335.90p +9.20%Zoopla Property Group (WI) (ZPLA) 214.00p +6.47%esure Group (ESUR) 235.00p +5.90%Croda International (CRDA) 2,215.00p +5.83%Laird (LRD) 310.00p +5.19%Playtech (PTEC) 737.50p +5.06%International Personal Finance (IPF) 480.00p +5.03%Keller Group (KLR) 797.50p +4.93%Ophir Energy (OPHR) 209.50p +4.23%Foxtons Group (FOXT) 205.30p +4.21%FTSE 250 - FallersSupergroup (SGP) 975.00p -5.25%Lonmin (LMI) 181.90p -2.83%AO World (AO.) 173.00p -2.54%Cairn Energy (CNE) 157.40p -2.36%Senior (SNR) 268.90p -2.36%Balfour Beatty (BBY) 161.80p -2.35%EnQuest (ENQ) 74.85p -1.84%Entertainment One Limited (ETO) 303.50p -1.78%African Barrick Gold (ABG) 195.00p -1.71%Poundland Group (PLND) 316.50p -1.71%
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.